JNJ
Johnson & JohnsonPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #107
- Final score
- 65.62
- Years on list
- 7
↗ Climbed 10 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 10 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 10 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 85 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | JNJ | BMY | ABBV |
|---|---|---|---|
| Climate Change | 67.7 | 82.1 | 73.5 |
| Employee Relations | 54.0 | 48.8 | 62.5 |
| Environment | 71.2 | 67.3 | 65.1 |
| Stakeholders & Society | 69.6 | 74.6 | 65.2 |
| Human Rights | 63.5 | 67.4 | 57.9 |
| Governance | 68.6 | 49.1 | 60.2 |
| Performance Rating | 71.5 | 69.2 | 68.1 |